Nearly all breast cancer survivors would recommend contrast-enhanced mammography for surveillance

A survey of 936 breast cancer survivors found 99.6% would recommend contrast-enhanced mammography (CEM) for post-treatment surveillance, despite 46.3% reporting moderate-to-high pre-exam anxiety. Satisfaction was 96.2%.

• 67.4% of women reported discomfort similar to that of digital mammography, and 77.4% reported comparable pain.
• Anxiety was linked to greater perceived discomfort, longer exam duration, and less reassurance before the exam.
• Clear communication about the procedure and addressing contrast concerns may improve the patient experience.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.